Go to main content

Diabetes Medications

Medications for Diabetes
Understanding Diabetes

Diabetes Medications

Latest Stories About Diabetes Medications

Vial of medication

Should You Microdose a GLP-1? Benefits and Risks

Key takeaways: * Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity. There are numerous reasons people may explore microdosing, including cost savings and minimizing side effects.  * Microdosing GLP-1 medications lacks clinical evidence, meaning doctors don’t have enough reliable data to confirm whether lower than approved doses are effective. * Compounded GLP-1 formulations, which may be used for microdosing, carry additional risks, including uncertain drug quality and imprecise dosing that may be especially dangerous for people who also take insulin.

Heart3 readers recommended

Tzield (Teplizumab) to Delay Type 1 Diabetes

Tzield has been shown to delay the onset of type 1 diabetes by an average of two years. Here’s more about screening and whether treatment may be right for you.

Heart119 readers recommended

Survodutide Shows Promising Weight Loss and Cardiometabolic Benefits

Survodutide is a new investigational dual GLP-1 injectable medication being tested for weight management in clinical trials.

Heart54 readers recommended

New Drug Retatrutide Shows Benefits for Diabetes and Weight Loss

Results from recent clinical trials suggest that retatrutide, a first-of-its-kind experimental drug, causes unprecedented levels of weight loss. Its effects on blood sugar for diabetes are comparable to currently available GLP-1 drugs like Ozempic. 

Heart179 readers recommended